{
  "book_page": 113,
  "pdf_page": 57,
  "content": {
    "main_concept": "Tuberculosis (TB)",
    "key_points": "**Rifampicin causes:**\\n- red orange discoloration of body secretions\\n- nausea\\n- vomiting\\n\\n**INH causes:**\\n- peripheral neuritis\\n- **3H**: hepatitis, hepatic enzyme elevation, hypersensitivity\\n\\n**Ethambutol causes:**\\n- optic neuritis (diminished red-green color discrimination)",
    "questions": [
      {
        "id": 1,
        "type": "multiple_choice",
        "question_text": "What is the purpose of the combination drug therapy for a client with tuberculosis (TB)?",
        "options": [
          "1. To prolong the effects of the drug",
          "2. To decrease the side effects of the drugs",
          "3. To decrease the deviation of the treatment",
          "4. To prevent the development of resistant strains of the TB organism"
        ],
        "correct_answer": "4",
        "rationale": "**RATIONALE**\\n\\nMulti-drug therapy for tuberculosis is required to prevent development of drug resistant strains of TB organism."
      }
    ]
  },
  "images": [],
  "extraction_metadata": {
    "timestamp": "2025-09-18T02:21:42Z",
    "extraction_confidence": "high",
    "human_validated": false,
    "notes": "Complete concept extracted from right side of PDF page 57. CONCEPT: Multi-drug therapy prevents development of resistant TB organism.",
    "category": "Pharmacological and Parenteral Therapies",
    "reference": "Handbook of Infectious Diseases, Pennsylvania, Springhouse"
  }
}